University of California San Francisco

Publications

  1. Gender-affirming facial surgery in racially, ethnically, and socioeconomically diverse individuals: Variations and consistencies in procedures and outcomes in a large cohort.
    Ramrakhiani NS, Sarpong L, McDaniel A, Falade I, Yim C, Hoffman W, Kim E, Pomerantz JH
    J Plast Reconstr Aesthet Surg. 2025 11; 110:98-105.; 
    PubMed
  2. Opioid-free Pain Management after Cleft Lip Repair.
    Do A, Rorison E, Borucki A, Shibata GS, Pomerantz JH, Hoffman WY
    Plast Reconstr Surg Glob Open. 2023 Sep; 11(9):e5259.; 
    PubMed
  3. Lipid nanoparticles for nucleic acid delivery to osteoblasts and osteoblast-lineage cells: A systematic review.
    Murphy AI, Vargas C, Pomerantz JH
    Bone Rep. 2026 Jun; 29:101921.; 
    PubMed
  4. Loss of transcriptional heterogeneity in aged human muscle stem cells.
    Barruet E, Striedinger K, Marangoni P, Pomerantz JH
    PLoS One. 2023; 18(5):e0285018.; 
    PubMed
  5. Rodent Model of Masseter Volumetric Muscle Loss for Studying Bioengineering Materials.
    Rohrer L, Striedinger K, Pomerantz J
    J Vis Exp. 2024 05 31; (207).; 
    PubMed
  6. Analyzing Linguistic Disparities in Telehealth Care Outcomes at a Multidisciplinary Craniofacial Center.
    Danial E, Rios J, Badiee R, Rosenbluth G, Pomerantz JH
    Cleft Palate Craniofac J. 2024 Dec; 61(12):2086-2089.; 
    PubMed
  7. Control of quiescence and activation of human muscle stem cells by cytokines.
    Striedinger K, Barruet E, Atamaniauc E, Linquist K, Knott C, Brack A, Pomerantz JH
    PLoS One. 2025; 20(12):e0327701.; 
    PubMed
  8. Long-pulsed neodymium-doped yttrium aluminum garnet for hair reduction in pediatric microtia repair.
    Braun M, Pomerantz JH, Hoffman WY, Mathes EF
    Pediatr Dermatol. 2023 Jul-Aug; 40(4):755-758.; 
    PubMed
  9. Acrylated Hyaluronic-Acid Based Hydrogel for the Treatment of Craniofacial Volumetric Muscle Loss.
    Rohrer L, Kato S, Browne SA, Striedinger-Melo K, Healy K, Pomerantz JH
    Tissue Eng Part A. 2024 11; 30(21-22):704-711.; 
    PubMed
  10. Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK).
    Perkins IU, Tan SY, McCalmont TH, Chou PM, Mully TW, Gerami P, Pomerantz JH, Reyes-Múgica M, Balkin DM, Kruse LL, Huang B, Reichek JL, Gangopadhyay N, Chiosea S, Green JR, Chamlin SL, Frieden IJ, Bastian BC, Yeh I
    Pigment Cell Melanoma Res. 2024 01; 37(1):6-14.; 
    PubMed